Leading The Charge On US Humira Competition, Organon Sets Out Strategy

US Biosimilars Head Jon Martin Talks Adalimumab And Further Opportunities Beyond

 
• By David Wallace
Jon Martin, Organon
Jon Martin discusses Organon’s US biosimilars strategy • Source: Organon

More from Biosimilars

More from Products